Adeno-associated viral vectors and their redirection to cell-type specific receptors (Q30885494)

27 June 2017

1 reference

title

Adeno-associated viral vectors and their redirection to cell-type specific receptors (English)

1 reference

27 June 2017

Stefan Michelfelder

1

1 reference

27 June 2017

Martin Trepel

series ordinal

2

1 reference

27 June 2017

language of work or name

1 reference

1 January 2009

1 reference

27 June 2017

1 reference

27 June 2017

volume

67

1 reference

27 June 2017

page(s)

29-60

1 reference

The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Steps toward mapping the human vasculature by phage display.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeting the prostate for destruction through a vascular address

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Selective and rapid uptake of adeno-associated virus type 2 in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

The epitope recognized by rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Improving rAAV production and purification: towards the definition of a scaleable process

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Yeast surface display for screening combinatorial polypeptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeting a Retroviral Vector in the Absence of a Known Cell-Targeting Ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus vectors in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Cell lines for the production of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Intracellular trafficking of adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Identification of PDGFR as a receptor for AAV-5 transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Anti-cancer activity of targeted pro-apoptotic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Gene expression from adeno-associated virus vectors in airway epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Altering AAV tropism with mosaic viral capsids.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Design and construction of targeted AAVP vectors for mammalian cell transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Generation and characterization of chimeric recombinant AAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Leukemia-targeting ligands isolated from phage-display peptide libraries.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Identification of a heparin-binding motif on adeno-associated virus type 2 capsids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Epitope selection from an uncensored peptide library displayed on avian leukosis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Avian leukosis virus is a versatile eukaryotic platform for polypeptide display

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Drug delivery in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Tumor targeting with a selective gelatinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Reversal of obesity by targeted ablation of adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Specific and efficient transduction of Cochlear inner hair cells with recombinant adeno-associated virus type 3 vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Aminopeptidase A is a functional target in angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Inverting enantioselectivity by directed evolution of hydantoinase for improved production of L-methionine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Self-complementary AAV vectors; advances and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Clinical gene therapy using recombinant adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Scalable production of adeno-associated virus type 2 vectors via suspension transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Cancer gene therapy using adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeted gene delivery to mammalian cells by filamentous bacteriophage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Characterization of adeno-associated virus genomes isolated from human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus types 5 and 6 use distinct receptors for cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Gene therapy: trials and tribulations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Molecular breeding of viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Rapid evolution of a protein in vitro by DNA shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Versatility of AAV vectors for retinal gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Peptides targeting caspase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Progress and problems with the use of viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A new look at the role of p53 in leukemia cell sensitivity to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Exploring vascular heterogeneity for gene therapy targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Molecular adaptors for vascular-targeted adenoviral gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

In vivo phage display and vascular heterogeneity: implications for targeted medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Structure of adeno-associated virus serotype 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Isolation of targeted AAV2 vectors from novel virus display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Engineering adeno-associated virus 2 vectors for targeted gene delivery to atherosclerotic lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Subcellular compartmentalization of adeno-associated virus type 2 assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Development of efficient viral vectors selective for vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adeno-associated virus serotypes: vector toolkit for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Gene transfer by adeno-associated virus vectors into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Production of recombinant adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2809%2967002-4

7 January 2021

10.1016/S0065-2660(09)67002-4

Identifiers

DOI

1 reference

27 June 2017

1 reference